Vaccine study aims to unlock secrets of Long-Term immunity
NCT ID NCT05272735
First seen Apr 19, 2026 · Last updated May 22, 2026 · Updated 4 times
Summary
This study looked at how the hepatitis B vaccine triggers the body's immune system, specifically focusing on memory B cells that help provide long-lasting protection. Healthy volunteers who had never been vaccinated against hepatitis B received the vaccine, and researchers analyzed samples from lymph nodes to understand how these memory cells respond to booster doses. The goal was to learn how to design better vaccines for fast-changing viruses like flu and HIV.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEPATITIS B are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
The Rockefeller University
New York, New York, 10065, United States
Conditions
Explore the condition pages connected to this study.